Nan Shan Life Insurance Co. Ltd. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 17.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 110,350 shares of the healthcare conglomerate’s stock after selling 23,050 shares during the period. Nan Shan Life Insurance Co. Ltd.’s holdings in UnitedHealth Group were worth $38,698,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. FMR LLC increased its holdings in UnitedHealth Group by 0.6% during the 4th quarter. FMR LLC now owns 52,565,986 shares of the healthcare conglomerate’s stock valued at $18,433,841,000 after purchasing an additional 295,642 shares during the period. Alliancebernstein L.P. boosted its position in UnitedHealth Group by 5.2% during the 4th quarter. Alliancebernstein L.P. now owns 11,485,225 shares of the healthcare conglomerate’s stock valued at $4,027,639,000 after acquiring an additional 569,142 shares in the last quarter. Morgan Stanley boosted its position in shares of UnitedHealth Group by 4.9% in the 3rd quarter. Morgan Stanley now owns 7,003,292 shares of the healthcare conglomerate’s stock worth $2,183,416,000 after purchasing an additional 325,936 shares in the last quarter. Sanders Capital LLC boosted its position in shares of UnitedHealth Group by 3.3% in the 3rd quarter. Sanders Capital LLC now owns 5,600,237 shares of the healthcare conglomerate’s stock worth $1,927,739,000 after purchasing an additional 178,100 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of UnitedHealth Group by 2.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 4,893,662 shares of the healthcare conglomerate’s stock worth $1,525,698,000 after purchasing an additional 99,425 shares in the last quarter. Hedge funds and other institutional investors own 86.03% of the company’s stock.

Shares of NYSE:UNH traded up $2.27 during midday trading on Tuesday, hitting $329.91. The company had a trading volume of 94,242 shares, compared to its average volume of 3,453,442. The company has a debt-to-equity ratio of 0.59, a current ratio of 0.82 and a quick ratio of 0.82. The company has a market cap of $313.03 billion, a price-to-earnings ratio of 18.82, a PEG ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a 12-month low of $187.72 and a 12-month high of $367.95. The company has a fifty day moving average of $341.25 and a two-hundred day moving average of $330.10.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 19th. The healthcare conglomerate reported $2.52 EPS for the quarter, topping the consensus estimate of $2.39 by $0.13. The firm had revenue of $65.47 billion during the quarter, compared to analyst estimates of $64.98 billion. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. UnitedHealth Group’s revenue was up 7.5% on a year-over-year basis. During the same period in the prior year, the business posted $3.90 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 16.75 earnings per share for the current fiscal year.

In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of the stock in a transaction dated Thursday, December 10th. The shares were sold at an average price of $342.00, for a total transaction of $855,000.00. Following the completion of the transaction, the director now owns 159,487 shares of the company’s stock, valued at approximately $54,544,554. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Thomas E. Roos sold 619 shares of the stock in a transaction dated Tuesday, February 9th. The shares were sold at an average price of $323.90, for a total transaction of $200,494.10. Following the transaction, the chief accounting officer now directly owns 31,908 shares of the company’s stock, valued at approximately $10,335,001.20. The disclosure for this sale can be found here. Insiders sold a total of 37,293 shares of company stock valued at $12,886,401 in the last ninety days. 0.80% of the stock is currently owned by insiders.

A number of analysts have recently commented on the company. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $360.00 to $430.00 in a research report on Wednesday, December 2nd. Credit Suisse Group boosted their price target on UnitedHealth Group from $355.00 to $395.00 and gave the stock an “average” rating in a research report on Thursday, November 5th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $404.00 to $409.00 and gave the company a “buy” rating in a research report on Thursday, January 21st. Truist upped their price objective on UnitedHealth Group from $400.00 to $420.00 in a research report on Tuesday, January 5th. Finally, Raymond James upped their price objective on UnitedHealth Group from $355.00 to $405.00 and gave the company a “strong-buy” rating in a research report on Wednesday, December 2nd. Five equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $387.82.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.

Featured Article: What are the benefits of a portfolio tracker?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.